Newsletter Signup
Video
Podcast
Contact Us
Advertise
Magazine
Log In
Register
Facebook icon
Twitter icon
YouTube icon
Instagram icon
LinkedIn icon
Automation
Finishing World
Made in America
New Products
Operations
Product Development
Safety
Software
Supply Chain
Home
Supply Chain
Tom Murphy
AP Business Writer
More from Tom Murphy
Product Development
Pfizer, U.S. Ink $5.29B Deal for Possible COVID-19 Treatment
The price for Pfizer’s potential treatment amounts to about $529 per course.
Operations
Johnson & Johnson to Split into 2 Companies
The company is the world’s biggest maker of health care products.
Operations
J&J CEO to Step Down
He's being replaced with another veteran company executive.
Operations
Amazon Bid to Address Soaring Health Costs is Over
Haven is quietly dissolving less than three years after it was formed.
Product Development
Lilly Stays Confident in Possible COVID Drug After Setback
The drugmaker maintains that its drug may stop COVID from developing in other patients.
Software
Outbreak Prompts Push to Telemedicine
Americans have been slow to embrace virtual care, but that may be changing.
Operations
Purdue Begins Bankruptcy Journey
Initial proceedings begin today for the OxyContin maker that filed for bankruptcy and negotiated a potential multi-billion dollar settlement.
Product Development
Eli Lilly to Sell Cheaper Insulin
The initial list price will be 50 percent lower than Humalog's current rate of about $275 per vial.
Operations
Drugmaker Rebates May Reach Consumers
Aetna and UnitedHealthcare both say they will begin passing rebates they get from drugmakers along to some customers starting next year.
Operations
Eli Lilly Cuts 3,500 Jobs
The company hopes to streamline by closing some facilities and moving production.
Operations
Pfizer Won't Split in Two
The maker of Viagra and the pain treatment Lyrica has been talking about a split for several years, thinking that two companies might grow faster than one.
Operations
Mylan Launching Cheaper EpiPen
The company, embroiled in criticism over its recent price hikes, has announced a generic version of the allergy treatment that is half the cost.